By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Knopp Biosciences 

2100 Wharton Street
Suite 615
Pittsburgh  Philadephia  15203  U.S.A.
Phone: 412-488-1776 Fax: n/a



Company News
Calman Prussin, M.D., Joins Knopp Biosciences To Lead Clinical Development Of Dexpramipexole In Eosinophilic Asthma 1/7/2016 1:27:56 PM
Knopp Biosciences Broadens Collaboration With National Institutes of Health (NIH) To Investigate Eosinophil-Lowering Effects Of Dexpramipexole 3/13/2014 8:59:43 AM
Knopp Biosciences And National Institutes of Health (NIH) To Collaborate In Evaluating Dexpramipexole In Patients With Hypereosinophilic Syndrome 1/8/2014 9:37:22 AM
Knopp Biosciences Partners With MMS Holdings, Inc. to Manage Pharmacovigilance Services 8/1/2013 12:50:09 PM
Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Strategic Contract With Knopp Biosciences 9/17/2012 10:31:20 AM
Knopp Biosciences Announces Recruiting of Key Scientific Executives and Completion of Laboratory Expansion 5/2/2012 10:14:11 AM
Data from Phase 2 Study of Knopp Biosciences's Dexpramipexole in ALS Published in Nature Medicine 11/21/2011 8:44:22 AM
Biogen Idec, Inc. (Massachusetts) (BIIB) and Knopp Biosciences Announce Enrollment of the First Patient in a Global Phase III Study of Dexpramipexole for ALS 3/31/2011 9:00:33 AM
Knopp NeuroSciences Forms New Parent Company, Knopp Biosciences to Expand Operations and Mission 10/14/2010 7:33:53 AM